Should I buy Centene Corporation (CNC) stock or is it too late?

Centene Corporation · Health Care · price $65

See the full Centene Corporation (CNC) profile

⭐ What the most reliable analysts say · those who beat their sector, targets replayed on real prices

⭐ The most reliable of them, either direction: Morgan Stanley — 69% of its targets hit on this sector (825 calls tested). It aims for $57 (-13 %), call made on June 5, 2026, maturing on June 5, 2027 (84 d ago).

The 11 reliable analysts $69+5.6 %

The 6 other firms $66+1.0 %

How to read it: the 11 reliable firms are not filtered by optimism — 8 aim above the price, 3 below, hence their $69 median. “The 6 others” are the firms that don't pass our reliability filter on this sector.

Firm-by-firm track record on Centene Corporation

Here the hit rate is measured <b>on this stock specifically</b> (matured targets replayed against real prices, minimum 5 calls tested) — the green block above measures reliability <b>across the whole sector</b>, which is the criterion behind JPI selections. “Aims for” = the firm's most recent target on this stock; “—” means it hasn't published one recently.

Firm	% right	Gain vs sector	Calls	Aims for
JP Morgan	60 %	+27.7 %	5	$67 +3%
Oppenheimer	53 %	+19.8 %	19	$58 -11%
Truist Securities	56 %	+17.1 %	9	$78 +19%
Deutsche Bank	56 %	+14.7 %	9	$80 +22%
Morgan Stanley	65 %	+12.5 %	26	$57 -13%
Jefferies	64 %	+8.8 %	14	$39 -40%
Cantor Fitzgerald	37 %	-3.6 %	19	$75 +15%
B of A Securities	67 %	-4.3 %	9	$74 +13%

In short — Should you invest in Centene Corporation? Is it too late, still worth it? Analysts are split (47% buy, median target $69, i.e. +6%), and the most reliable on CNC targets even higher. But it pays virtually no dividend. We give you both sides, with the numbers — not advice.

✅ Reasons to believe

The most reliable firm on CNC, B of A Securities (67% hit rate, 9 scored calls), targets $74 (call made on June 4, 2026, maturing on June 4, 2027) (+13%) in its most recent call, and $60 (call made on April 29, 2026, maturing on April 29, 2027) (-8%) in the one coming due soonest.
5 analysts rated reliable (≥55% hit rate, beat their sector) are bullish on the stock.

⚠️ Reasons to hesitate

The consensus is not unanimous: of 17 ratings, 9 are neutral.
Limited upside: the median target is only +6% from the current price.
A 12-month target is not a guaranteed path: the price can fall in the meantime.
No dividend: your return depends only on price appreciation.

The analyst consensus on CNC

Median target $69 (+6%) · 17 ratings · Hold consensus

Strong Buy00%

Buy847%

Hold953%

Sell00%

Strong Sell00%

⚠️ Information, not investment advice. Past performance does not guarantee future results. Analyst targets on a ~12-month horizon.

Frequently asked questions

Should you invest in Centene Corporation now?

We won't decide for you. The facts: 47% of analysts rate it a buy, median target $69 (+6%), and B of A Securities (most reliable on CNC, 67%) targets $74. Weigh that against valuation. This is not personalized advice.

Is it too late to invest in Centene Corporation?

Not according to analysts: the median target ($69) is still +6% above the current price ($65) (most reliable on CNC: B of A Securities, 67%). The real question isn't "too late" but the price-to-value gap and risk. Not advice.

Is Centene Corporation still worth investing in?

It depends on the gap between the price ($65) and its estimated value: analysts target $69 on median (+6%), with 47% buys (most reliable on CNC: B of A Securities, 67%). Cross-check with their real reliability on CNC and the cautions above. Information, not advice.

What's the main risk in buying CNC?

The consensus is not unanimous: of 17 ratings, 9 are neutral.

→ Go deeper: the full Centene Corporation profile (consensus, analyst reliability, price target, performance).